Back
 OJRA  Vol.4 No.3 , August 2014
Anticardiolipin Antibody Isotype Determination in Amniotic Fluid of Pregnant Patients with Systemic Lupus Erythematosus and/or Antiphospholipid Syndrome
Abstract: Objective: To determine the levels and isotypes of aCl, as well as anti beta 2 glycoprotein 1 (antiβ2-GP1) antibodies in serum and amniotic fluid of pregnant patients with SLE and/or APLS, and healthy pregnant women serving as a control group. Material and Methods: We analyzed serum and amniotic fluid of pregnant patients with SLE and/or APLS, and of healthy pregnant women through ELISA. Results were compared using a Student’s T test. Results: 6 of 13 patients (46.1%), 5 with SLE and one with primary APLS had antiphospholipid antibodies in amniotic fluid. Two patients had IgG aCl and 4 patients had antiβ2-GP1 (one of them also showing IgM) in amniotic fluid. In serum, 4 patients (30%) had antiphospholipid antibodies present (one IgG aCl and three anti β2-GP1) as opposed to none in the control group having antiphospholipid antibodies in amniotic fluid. Only one control had IgM aCl in serum. Antiβ2-GP1 in the amniotic fluid of patients showed a statistically significant value when compared to controls. Conclusion: aCl and antiβ2-GP1 may be present in the amniotic fluid of patients with and without a history of fetal loss. The presence of IgM aCl and antiβ2-GP1 in amniotic fluid suggests its localized production.
Cite this paper: Daniel, X. , Carmen, S. , Polita, C. , Ignacio, G. and Javier, J. (2014) Anticardiolipin Antibody Isotype Determination in Amniotic Fluid of Pregnant Patients with Systemic Lupus Erythematosus and/or Antiphospholipid Syndrome. Open Journal of Rheumatology and Autoimmune Diseases, 4, 170-177. doi: 10.4236/ojra.2014.43024.
References

[1]   Branch, D., Scott, J., Kochenour, N. and Hershgold, E. (1985) Obstetric Complications Associated with the Lupus Anticoagulant, The New England Journal of Medicine, 313, 1322-1326.
http://dx.doi.org/10.1056/NEJM198511213132104

[2]   Love, P. and Stantoro, S. (1990) Antiphospholipid Antibodies: Anticardiolipin and the Lupus Anticoagulant in Systemic Lupus Erythematosus (SLE) and Non-SLE Disorders. Annals of Internal Medicine, 11, 682-688.
http://dx.doi.org/10.7326/0003-4819-112-9-682

[3]   Silver, R., MacGregor, S. and Pasternak, J. (1992) Neely S, Fetal Stroke Associated with Elevated Maternal Anticardiolipin Antibodies. Obstetrics and Gynecology, 880, 497-499.

[4]   De Klerk, O., De Vries, T. and Sinnige, L. (1997) An Unusual Case of Neonatal Seizures in a New Born Infant. Pediatrics, 100, E8.
http://dx.doi.org/10.1542/peds.100.4.e8

[5]   Cohen, S., Goldenberg, M., Rabinovici, J., Lidor., A., et al. (1999) Anticardiolipin Antibodies in Fetal Blood and Amniotic Fluid From Patients with the Antiphospholipid Syndrome. Human Reproduction, 15, 1170-1172.
http://dx.doi.org/10.1093/humrep/15.5.1170

[6]   Botet, F., Romera, G., Montagut, P., et al. (1997) Neonatal Outcome in Women Treated for Antiphospholipid Syndrome during Pregnancy. Journal of Perinatal Medicine, 23, 192-196.
http://dx.doi.org/10.1515/jpme.1997.25.2.192

[7]   Ramos Niembro F. (1999) Lupus eritematoso generalizado, y síndrome antifosfolípido. En: Enfermedades Reumáticas: clasificación y diagnóstico, 1a ed, Mc Graw-Hill Interamericana, México.

[8]   Cowchock, F., Reece, E., Balaban, D., Branco, D., et al. (1992) Repeated Fetal Losses Associated with Antiphospholipid Antibodies: A Collaborative Randomized Trial Comparing Prednisone to Low-Dose Heparin Treatment. American Journal of Obstetrics & Gynecology, 166, 1318-1323.
http://dx.doi.org/10.1016/0002-9378(92)91596-3

[9]   Holers, V., Girardi, G., Mo. L., et al. (2002) Complement C3 Activation Is Required for Antiphospholipid Antibody Induced Fetal Loss. The Journal of Experimental Medicine, 195, 211-220.
http://dx.doi.org/10.1084/jem.200116116

[10]   Lai, N. and Lan, J. (2000) Evaluation of Cerebrospinal Anticardiolipin Antibodies in Lupus Patients with Neuropsychiatric Manifestations. Lupus, 9, 353-357.
http://dx.doi.org/10.1191/096120300678828415

[11]   Geis, W. and Branch, D.W. (2001) Obstetric Implications of Antiphospholipid Antibodies: Pregnancy Loss and Other Complications. Clinical Obstetrics & Gynecology, 44, 2-10.
http://dx.doi.org/10.1097/00003081-200103000-00002

 
 
Top